Mbiri Yekambani
Beijing Succeeder Technology Inc. (ichazonzi SUCCEEDER), iri muLife Science Park muBeijing China, yakavambwa muna 2003, SUCCEEDER inyanzvi muzvigadzirwa zvekuongorora thrombosis uye hemostasis pamusika wepasi rose.
Seimwe yemhando dzinotungamira mumusika weChina wekuongorora Thrombosis neHemostasis, SUCCEEDER yakasangana nezvikwata zveR&D, Production, Marketing, Sales and Service, Kupa macoagulation analyzers nema reagents, blood rheology analyzers, ESR neHCT analyzers, platelet aggregation analyzers, neISO 13485, CE Certification, uye FDA yakanyorwa.
R&D
Seimwe yemhando dzinotungamira mumusika weChina wekuongorora Thrombosis neHemostasis, SUCCEEDER yakasangana nezvikwata zveR&D, Production, Marketing, Sales and Service, Kupa macoagulation analyzers nema reagents, blood rheology analyzers, ESR neHCT analyzers, platelet aggregation analyzers, neISO 13485, CE Certification, uye FDA yakanyorwa.
Kubva payakatangwa muna 2003, Succeeder yave ichishanda mukutsvaga nekugadzira, kugadzira nekutengesa zvishandiso zvekuyedza, ma reagents uye zvinodyiwa mumunda we thrombosis uye hemostasis in vitro diagnostics, ichipa zvipatara zvishandiso zvekuyedza otomatiki zvekuvharika kweropa, rheology yeropa, hematocrit, platelet aggregation, zvinotsigira ma reagents uye zvinodyiwa. Succeeder ow ikambani inotungamira mukugadzira muChina mumunda wekuongorora thrombosis uye hemostasis in vitro.
Tekinoroji huru yaSucceeder inosanganisira zvishandiso, ma reagents uye zvinoshandiswa yagadzirwa, iine hunyanzvi hwakazvimiririra hweR&D uye tekinoroji. Parizvino, ine zvikamu zvishanu zvetekinoroji huru: puratifomu yekuyera rheology yeropa, puratifomu yetekinoroji yekuyedza kuvharika kweropa, puratifomu yetekinoroji yezvinhu zvakabikwa, tekinoroji huru yekuongorora kuvharika kweropa, uye nzira dzekutevera.
Chiitiko Chinokosha
Kukosha
Kuvandudza tekinoroji yekuyera uye mwero we otomatiki wevayedzi ve coagulation varipo uye vayedzi ve rheology yeropa;
(2) Mutsetse weR&D Coagulation, muyedzi wekudzikisa ropa nekukurumidza, muyedzi wekudzikisa ropa nekukurumidza, muyedzi wekuongorora mashandiro eplatelet otomatiki uye chati ye thromboelasticity nezvimwe zvigadzirwa zvakatevedzana;
(3) Kugadzira zvinhu zvakakosha zvekugadzira zvinhu zvemhando yepamusoro, uchishandisa tekinoroji yezvigadzirwa zvemhando yepamusoro, kunatsiridza mhando uye mashandiro ezvigadzirwa zve reagent;
(4) Gadzira vWF, LA, PC, PS, Anti-Xa, diluted thrombin time measurement (dTT), blood coagulation factor VIII uye blood coagulation factor IX nezvimwe zvinoshandiswa mu in vitro diagnostic reagents uye zvinotsigira kudzorwa kwemhando yepamusoro. Zvigadzirwa nezvigadzirwa zvakajairwa zvinosangana nezvinodiwa zvekiriniki zvekuongorora nekutarisa thrombus, antiphospholipid syndrome, hemophilia nezvimwe zvirwere, uye kuchengetedza mabhenefiti ehunyanzvi aSucceeder mumunda wekuongorora thrombosis ne hemostasis mu in vitro.
Chitupa
Kadhi rebhizinesi
WeChat yeChinese